Invention Application
- Patent Title: HETEROARYL-SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
-
Application No.: US17183401Application Date: 2021-02-24
-
Publication No.: US20220348570A1Publication Date: 2022-11-03
- Inventor: Jean-Christophe Andrez , Kristen Nicole Burford , Christoph Martin Dehnhardt , Thilo Focken , Michael Edward Grimwood , Qi Jia , Verner Alexander Lofstrand , Shaoyi Sun , Steven Sigmund Wesolowski , Michael Scott Wilson , Alla Yurevna Zenova
- Applicant: Xenon Pharmaceuticals Inc.
- Applicant Address: CA Burnaby
- Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee: Xenon Pharmaceuticals Inc.
- Current Assignee Address: CA Burnaby
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D401/12 ; C07D401/14 ; C07D409/12 ; C07D413/12 ; C07D417/12 ; C07D471/04 ; C07D487/08
Abstract:
This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.
Public/Granted literature
- US11639351B2 Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents Public/Granted day:2023-05-02
Information query
